Why is Ind-Swift Labs. falling/rising?

As of 26-Sep, Ind-Swift Laboratories Ltd is experiencing a decline in its stock price, currently at 99.34, which reflects a decrease of 3.9 or 3.78%. The stock has underperformed its sector by 1.44% today and has been on a consecutive fall for the last two days, resulting in a total drop of 4.94% during this period. It opened the day with a loss of 2.12% and reached an intraday low of Rs 98.11, marking a decline of 4.97%. Over the past week, the stock has decreased by 5.30%, while its performance over the last month shows a modest increase of 4.24%. However, year-to-date, the stock is down 9.44%, and over the past year, it has fallen by 25.31%. Notably, the stock's delivery volume has significantly decreased, falling by 79.37% against the 5-day average, indicating reduced investor participation.
In the broader market context, the Sensex has declined by 2.66% over the past week, suggesting that the stock's short-term performance is worse than the benchmark. The pharmaceuticals and drugs sector, in which Ind-Swift operates, has also seen a downturn of 2.34%. Despite the stock being higher than its 100-day and 200-day moving averages, it is currently below its 5-day, 20-day, and 50-day moving averages, indicating a bearish trend. The overall market sentiment appears to be negative, contributing to the stock's recent struggles.